SPC-Flakes® stimulate the body’s own production of protein AF. Antisecretory Factory (AF) is a protein that is naturally present in the body.
PATIENT INSTRUCTION CAN BE DOWNLOADED.
SPC-Flakes® are specially produced outmeals that are made with a unique and patented production method. SPC is an abbreviation of ”Specially Processed Cereals” SPC-Flakes® is a kind ”maintenance” treatment where the goal is the stimulate the body’s own production of protein AF. Antisecretory Factory (AF) is a protein that is naturally present in the body.
SPC-Flakes® can normalize fluid flow. This is of clinical significance within bowel diseases, diarrhea, Mèniére and Mastitis.
SPC-Flakes® have also been shown to have an anti-inflammatory effect which was seen in studies of inflammatory bowel disease (IBD) like Colitis Ulcerosa and Crohn’s disease, rheumatoid arthritis and mastitis.
Abstracts from the satelite symposium Antisecretory Factor and Medical Food – Novel therapy concepts, at the 7th International Symposium on Meniere´s Disease and Inner Ear Disorders in Rome, October 17-20, 2015.
Samuel C.Leong, MPhil, FRCS(ORL-HNS); Surya Narayan, MS, DLO, FRCS(ORL-HNS); Tristram H. Lesser, MS, FRCSS.
Antisecretory Factor–Inducing Therapy Improves Patient-Reported Functional Levels in Meniere’s Disease, Annals of Otology, Rhinology & Laryngology 122(10):619-624.
Hanner, Rask-Andersen, Lange and Jennische, Antisecretory factor-inducing therapy improves the clinical outcome in patients with Ménière’s disease, Acta Oto-Laryngologica, 2010; 130:223-227.
Svensson, Lange, Lönnroth, Widström and Hanson, Induction of antisecretory factor in human milk may prevent mastitis, Acta Paediatrica Scandinavia 93:1228-1231, 2004.
Laurenius, Wängberg, Lange, Jennische, Lundgren and Bosaeus, Antisecretory factor counteracts secretory diarrhoea of endocrine origin, Clinical Nutrition, 2003; 22(6):549-542.
Mörck, Ek, Jennische, Laurenius, Tarkowski och Lange, Anti-inflammatorisk effekt av kosttillskott med specialprocessade cerealier vid reumatoid artrit – en dubbel-blind pilotstudie, Posterpresentation vid Riksstämman, 2003.